05 Aug 2026
byProf. Sophelia Chan, Department of Paediatrics and Adolescent Medicine, University of Hong Kong
Spinal muscular atrophy (SMA) is an inherited
neuromuscular disorder that causes progressive muscle weakness and wasting,
resulting in loss of motor function. The oral drug risdiplam demonstrated
improvement or stabilization of motor function in clinical studies of patients
with SMA. Professor Sophelia Chan of the Department of Paediatrics and
Adolescent Medicine, University of Hong Kong, shared the latest published local
findings on treatment outcomes with risdiplam in paediatric and adult patients
with SMA.